Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction.

Source:http://linkedlifedata.com/resource/pubmed/id/8542954

Download in:

View as

General Info

PMID
8542954